IGC Pharma (IGC) News Today $0.33 +0.00 (+0.28%) Closing price 03:58 PM EasternExtended Trading$0.33 0.00 (-0.31%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipSEC FilingsBuy This Stock IGC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period IGC Pharma, Inc.: IGC Pharma's Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer's MarketMay 22, 2025 | finanznachrichten.deOtsuka Holdings Stock Price, Quotes and Forecasts | OTC:OTSKY | BenzingaMay 22, 2025 | benzinga.comIGC Pharma, Inc.: IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC-AD1, at the 2025 Genetic Toxicology Association MeetingMay 12, 2025 | finanznachrichten.deIGC Pharma announces strategic investment from advisorsApril 25, 2025 | markets.businessinsider.comIGC Pharma expands CALMA trial with addition of Butler Hospital ProgramApril 9, 2025 | markets.businessinsider.comIGC Pharma, Inc.: IGC Pharma Expands CALMA Alzheimer's Phase 2 Trial with Prestigious Research Site at Butler Hospital's Memory and Aging ProgramApril 8, 2025 | finanznachrichten.deIGC Pharma announces CALMA Phase 2 trial expansion with Miami Jewish HealthApril 2, 2025 | markets.businessinsider.comIGC Pharma expands CALMA clinical trialApril 2, 2025 | markets.businessinsider.comIGC Pharma announces additional interim results from IGC-AD1 trialMarch 28, 2025 | markets.businessinsider.comIGC Pharma announces interim data from Phase 2 trial of IGC-AD1March 28, 2025 | markets.businessinsider.comIGC Pharma, Inc.: IGC Pharma's Phase 2 Clinical Trial Interim Data Demonstrates Significant Reduction in Sleep DisturbancesMarch 27, 2025 | finanznachrichten.deIGC Pharma posts promising interim data for Alzheimer’s therapyMarch 27, 2025 | finance.yahoo.comIGC Pharma announces CALMA Phase 2 trial expansionMarch 21, 2025 | markets.businessinsider.comIGC adds new clinical site in Canada for Alzheimer’s agitation therapy trialMarch 21, 2025 | finance.yahoo.comIGC Pharma, Inc.: IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Canadian Hamilton Health SciencesMarch 20, 2025 | finanznachrichten.deIGC Pharma, Inc.: IGC Pharma Expands CALMA Trial with Addition of BayCare Health System in FloridaMarch 17, 2025 | finanznachrichten.deIGC Pharma expands CALMA trial with addition of BayCare Health SystemMarch 17, 2025 | markets.businessinsider.comIGC Pharma, Inc. (IGC) Advances AI Model to Enhance Alzheimer’s DiagnosisMarch 6, 2025 | insidermonkey.comIGC Pharma, Inc.: IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer's and Dementia DetectionMarch 4, 2025 | finanznachrichten.deIGC Pharma develops AI-driven model to improve diagnosis of Alzheimer’sMarch 4, 2025 | markets.businessinsider.comIGC Pharma reports Q3 EPS (2c) vs. (9c) last yearFebruary 20, 2025 | markets.businessinsider.comIGC Pharma expands Holiby line with ‘Longevity’, ‘Renew’February 20, 2025 | markets.businessinsider.comIGC Pharma, Inc.: IGC Pharma Reports Third Quarter Fiscal 2025 ResultsFebruary 18, 2025 | finanznachrichten.deIGC Pharma, Inc.: IGC Pharma Expands Into $75 Billion Wellness Market with the Launch of HolibyFebruary 11, 2025 | finanznachrichten.deIGC Pharma Appoints Former Virginia Governor Terry McAuliffe as Strategic AdvisorJanuary 21, 2025 | markets.businessinsider.comIGC Gains on Word of Alzheimer’s TreatmentJanuary 9, 2025 | baystreet.caIGC Pharma names IGC-AD1 Phase 2 clinical trial ‘CALMA’January 9, 2025 | markets.businessinsider.comIGC Pharma, Inc.: IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025December 20, 2024 | finanznachrichten.deIGC Pharma expands clinical research program for IGC-AD1December 2, 2024 | markets.businessinsider.comIGC Pharma Advances IGC-AD1 as a Potential Alzheimer's Therapy Addressing Cognitive Impairment and Underlying Disease PathologyDecember 2, 2024 | finance.yahoo.comIGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's TreatmentNovember 25, 2024 | businesswire.comIGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s PipelineNovember 14, 2024 | markets.businessinsider.comIGC Pharma announces publication of IMS Spotlight interviewNovember 7, 2024 | markets.businessinsider.comIGC Pharma (AMEX:IGC) Stock, Short Interest ReportSeptember 29, 2024 | benzinga.comInsider Buying: IGC Pharma, Inc. (NYSEMKT:IGC) Director Acquires 588,235 Shares of StockSeptember 28, 2024 | insidertrades.comIGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's TreatmentSeptember 18, 2024 | finance.yahoo.comThe Analyst Verdict: IGC Pharma In The Eyes Of 4 ExpertsSeptember 4, 2024 | benzinga.comIGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's DiseaseSeptember 4, 2024 | finance.yahoo.comBioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Announces Stockholders’ Approval of All Disclosed Proposals at 2024 Annual MeetingAugust 27, 2024 | msn.comIGC Announces Results of its 2024 Annual Stockholders MeetingAugust 27, 2024 | finance.yahoo.com Get IGC Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for IGC and its competitors with MarketBeat's FREE daily newsletter. Email Address IGC Media Mentions By Week IGC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IGC News Sentiment▼0.280.93▲Average Medical News Sentiment IGC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IGC Articles This Week▼21▲IGC Articles Average Week Get IGC Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for IGC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Virios Therapeutics News Today Caribou Biosciences News Today Genelux News Today Xtant Medical News Today Coya Therapeutics News Today C4 Therapeutics News Today MacroGenics News Today OptiNose News Today OncoCyte News Today Zomedica News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEMKT:IGC) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored“You all just got a lot richer”Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crash...Brownstone Research | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGC Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGC Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
